Title : Use of GLP1-RAs in patients with a history of cholelithiasis Author: Sarah Hughes, PharmD Candidate 2024 University of Rhode Island, School of Pharmacy Reviewer: Courtney Cameron, PharmD, BCACP Background Cholelithiasis, also known as gallstones, are hardened collections of bile materials such as cholesterol or bilirubin that collect at the bottom of the gallbladder
Tirzepatide works for weight loss through a dual-action mechanism targeting the pathways in the body that control both glucose metabolism and appetite
Injectable GLP-1 and dual agonists command 78.4% of total drug revenue
This helps to prevent blood glucose levels from falling too low and causing hypoglycemia
By promoting cell migration to the site of an injury, it helps the cells that rebuild tissue reach where they are needed
T., Polex-Wolf, J., Prevot, V., Raun, K., Simonsen, L., Hogendorf, W